Intrauterine growth restriction: postnatal monitoring and outcomes
Intrauterine growth restriction (IUGR) continues to be a challenging problem for clinicians
despite advances in both obstetric and neonatal care. IUGR is defined as a rate of fetal …
despite advances in both obstetric and neonatal care. IUGR is defined as a rate of fetal …
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem
Over the past 10 years, knowledge of the burden, economic costs, and consequences of
malaria in pregnancy has improved, and the prevalence of malaria caused by Plasmodium …
malaria in pregnancy has improved, and the prevalence of malaria caused by Plasmodium …
[BOOK][B] World malaria report 2023
World Health Organization - 2023 - books.google.com
Page 1 World malaria וייוייו report 2023 wwwwww World Health Organization Page 2 World
malaria report 2023 ISBN 978-92-4-008617-3 (electronic version) ISBN 978-92-4-008618-0 …
malaria report 2023 ISBN 978-92-4-008617-3 (electronic version) ISBN 978-92-4-008618-0 …
Intrauterine growth restriction–part 1
D Sharma, S Shastri, N Farahbakhsh… - The journal of maternal …, 2016 - Taylor & Francis
Intrauterine growth restriction (IUGR) is a major and silent cause of various morbidity and
mortality for the fetal and neonatal population. It is defined as a rate of fetal growth that is …
mortality for the fetal and neonatal population. It is defined as a rate of fetal growth that is …
Birth weight, malnutrition and kidney-associated outcomes—a global concern
VA Luyckx, BM Brenner - Nature Reviews Nephrology, 2015 - nature.com
An adverse intrauterine environment is associated with an increased risk of elevated blood
pressure and kidney disease in later life. Many studies have focused on low birth weight …
pressure and kidney disease in later life. Many studies have focused on low birth weight …
Prevention of malaria in pregnancy
Malaria remains one of the most preventable causes of adverse birth outcomes. Intermittent
preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine is used to prevent …
preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine is used to prevent …
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine …
Background Every year, more than 32 million pregnancies in sub-Saharan Africa are at risk
of malaria infection and its adverse consequences. The effectiveness of the intermittent …
of malaria infection and its adverse consequences. The effectiveness of the intermittent …
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
SB Sirima, L Richert, A Chêne, AT Konate… - The Lancet Infectious …, 2020 - thelancet.com
Background PRIMVAC is a VAR2CSA-derived placental malaria vaccine candidate aiming
to prevent serious clinical outcomes of Plasmodium falciparum infection during pregnancy …
to prevent serious clinical outcomes of Plasmodium falciparum infection during pregnancy …
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a …
Summary Background Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine
threatens the antimalarial effectiveness of intermittent preventive treatment during …
threatens the antimalarial effectiveness of intermittent preventive treatment during …
[HTML][HTML] Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a …
Summary Background The ongoing Ebola epidemic in parts of west Africa largely
overwhelmed health-care systems in 2014, making adequate care for malaria impossible …
overwhelmed health-care systems in 2014, making adequate care for malaria impossible …